annual EBITDA:
-$141.87M-$37.28M(-35.65%)Summary
- As of today (September 16, 2025), OLMA annual EBITDA is -$141.87 million, with the most recent change of -$37.28 million (-35.65%) on December 31, 2024.
- During the last 3 years, OLMA annual EBITDA has fallen by -$70.54 million (-98.89%).
- OLMA annual EBITDA is now -6464.78% below its all-time high of -$2.16 million, reached on December 31, 2018.
Performance
OLMA EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBITDA:
N/ASummary
- OLMA quarterly EBITDA is not available.
Performance
OLMA quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Range
Earnings dates
TTM EBITDA:
N/ASummary
- OLMA TTM EBITDA is not available.
Performance
OLMA TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
OLMA EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -35.6% | - | - |
| 3 y3 years | -98.9% | - | - |
| 5 y5 years | -3193.8% | - | - |
OLMA EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -98.9% | at low | ||||
| 5 y | 5-year | -3193.8% | at low | ||||
| alltime | all time | -6464.8% | at low |
OLMA EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$34.74M(-5.2%) | -$142.36M(+0.3%) |
| Dec 2024 | -$141.87M(+35.6%) | -$36.65M(-2.3%) | -$141.87M(+4.7%) |
| Sep 2024 | - | -$37.53M(+12.2%) | -$135.54M(+11.8%) |
| Jun 2024 | - | -$33.44M(-2.4%) | -$121.27M(+11.2%) |
| Mar 2024 | - | -$34.25M(+12.9%) | -$109.01M(+4.9%) |
| Dec 2023 | -$104.58M(-1.9%) | -$30.33M(+30.4%) | -$103.93M(+3.5%) |
| Sep 2023 | - | -$23.25M(+9.8%) | -$100.40M(+0.4%) |
| Jun 2023 | - | -$21.18M(-27.4%) | -$99.95M(-10.5%) |
| Mar 2023 | - | -$29.18M(+8.9%) | -$111.66M(+6.0%) |
| Dec 2022 | -$106.63M | -$26.80M(+17.5%) | -$105.33M(+6.7%) |
| Sep 2022 | - | -$22.80M(-30.7%) | -$98.72M(+5.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | -$32.88M(+43.9%) | -$93.63M(+21.2%) |
| Mar 2022 | - | -$22.85M(+13.2%) | -$77.23M(+10.6%) |
| Dec 2021 | -$71.33M(+232.4%) | -$20.18M(+14.0%) | -$69.83M(+16.8%) |
| Sep 2021 | - | -$17.71M(+7.4%) | -$59.77M(+19.7%) |
| Jun 2021 | - | -$16.49M(+6.8%) | -$49.92M(+39.0%) |
| Mar 2021 | - | -$15.44M(+52.5%) | -$35.92M(+66.9%) |
| Dec 2020 | -$21.46M(+398.2%) | -$10.13M(+28.7%) | -$21.52M(+73.5%) |
| Sep 2020 | - | -$7.87M(+216.7%) | -$12.40M(+173.3%) |
| Jun 2020 | - | -$2.48M(+138.8%) | -$4.54M(+120.9%) |
| Mar 2020 | - | -$1.04M(+2.6%) | -$2.05M(+102.6%) |
| Dec 2019 | -$4.31M(+99.3%) | -$1.01M | -$1.01M |
| Dec 2018 | -$2.16M | - | - |
FAQ
- What is Olema Pharmaceuticals, Inc. annual EBITDA?
- What is the all time high annual EBITDA for Olema Pharmaceuticals, Inc.?
- What is Olema Pharmaceuticals, Inc. annual EBITDA year-on-year change?
- What is the all time high quarterly EBITDA for Olema Pharmaceuticals, Inc.?
- What is the all time high TTM EBITDA for Olema Pharmaceuticals, Inc.?
What is Olema Pharmaceuticals, Inc. annual EBITDA?
The current annual EBITDA of OLMA is -$141.87M
What is the all time high annual EBITDA for Olema Pharmaceuticals, Inc.?
Olema Pharmaceuticals, Inc. all-time high annual EBITDA is -$2.16M
What is Olema Pharmaceuticals, Inc. annual EBITDA year-on-year change?
Over the past year, OLMA annual EBITDA has changed by -$37.28M (-35.65%)
What is the all time high quarterly EBITDA for Olema Pharmaceuticals, Inc.?
Olema Pharmaceuticals, Inc. all-time high quarterly EBITDA is -$1.01M
What is the all time high TTM EBITDA for Olema Pharmaceuticals, Inc.?
Olema Pharmaceuticals, Inc. all-time high TTM EBITDA is -$1.01M